i3 Health's mission is to enhance the proficiency of the multidisciplinary health care team by providing evidence-based, fair-balanced CME/NCPD/CPE activities that address identified professional practice gaps and unmet educational needs.
…
continue reading
1
Practice-Changing Advances in the Management of Hemophilia
42:37
42:37
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
42:37
In this podcast, hear expert perspectives on practice-changing advances in the treatment and personalized management of patients with hemophilia from Dr. Guy Young, Director of the Hemostasis and Thrombosis Program, Attending Physician in Hematology/Oncology, and Professor of Pediatrics at Keck School of Medicine of USC; and Dr. Jennifer Davila, Co…
…
continue reading
1
Early-Stage Non–Small Cell Lung Cancer: Answers to Frequently Asked Questions
5:58
5:58
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
5:58
In this video, Dr. Jamie E. Chaft, Associate Attending Physician at Memorial Sloan Kettering Cancer Center, answers questions asked by the audience during her CME/NCPD–approved activity with i3 Health, Leveraging the Growing Arsenal of Therapies for Early-Stage Non–Small Cell Lung Cancer (NSCLC), chaired by Dr. Helena Yu. Dr. Chaft shares insights …
…
continue reading
1
Cold Agglutinin Disease: Answers to Frequently Asked Questions With Catherine Broome, MD
4:53
4:53
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
4:53
In this video, Dr. Catherine M. Broome, Professor of Medicine at Georgetown University Medical Center, answers questions asked by the audience during her CME/NCPD–approved activity with i3 Health, Putting the Freeze on Cold Agglutinin Disease (CAD). Dr. Broome shares insights into resources she recommends for patients with CAD, the role of thrombop…
…
continue reading
1
Getting Ahead of the ALS Curve: Module 2 – Disease-Modifying Therapies for ALS: Weighing the Options
16:55
16:55
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
16:55
In Module 2 of this microlearning series and podcast, Dr. Sabrina Paganoni, Co-Director of the Neurological Clinical Research Institute at Massachusetts Hospital and Healey & AMG Center for ALS, and Associate Professor of Physical Medicine and Rehabilitation (PM&R) at Spaulding Rehabilitation Hospital of Harvard Medical School, will share strategie…
…
continue reading
1
Getting Ahead of the ALS Curve: Module 1 – Enabling Earlier Detection of ALS
24:10
24:10
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
24:10
In Module 1 of this microlearning series and podcast, Dr. Sabrina Paganoni, Co-Director of the Neurological Clinical Research Institute at Massachusetts Hospital and Healey & AMG Center for ALS, and Associate Professor of Physical Medicine and Rehabilitation (PM&R) at Spaulding Rehabilitation Hospital of Harvard Medical School, will share strategie…
…
continue reading
1
Additional Advances in Triple-Negative Breast Cancer Research and Trials: Sara M. Tolaney, MD, MPH
7:22
7:22
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
7:22
Last year, Dr. Sara Tolaney, Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, served as co-chair of i3 Health’s webinar and online activity, Pathology and Oncology Expert Perspectives in the Management of Triple-Negative Breast Cancer (TNBC). With numerous advances in TNBC research occurring since then, Dr. Tolaney sat down…
…
continue reading
1
Additional Advances in Multiple Myeloma Research and Clinical Trials With Rahul Banerjee, MD, FACP
5:54
5:54
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
5:54
Dr. Rahul Banerjee, Assistant Professor in the Division of Medical Oncology at the University of Washington, Fred Hutchinson Cancer Center, is currently serving as chair of i3 Health’s online activity and fellows meeting series, Leveraging BCMA-Directed Therapies for Improved Patient Outcomes in Relapsed/Refractory Multiple Myeloma. Since recording…
…
continue reading
1
Acid Sphingomyelinase Deficiency: Answers To Frequently Asked Questions With Neal Weinreb, MD
11:15
11:15
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
11:15
In this video, Dr. Neal Weinreb, Voluntary Associate Professor for Human Genetics at the University of Miami Miller School of Medicine, answers questions asked by the audience during his CME/NCPD–approved activity with i3 Health, Exploring Treatment Advances for Acid Sphingomyelinase Deficiency (ASMD) in Adults. Dr. Weinreb shares insights into scr…
…
continue reading
1
Recurrent/Metastatic HNSCC: Answers To Frequently Asked Questions With Assuntina G. Sacco, MD
11:15
11:15
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
11:15
In this video, Dr. Assuntina G. Sacco, Associate Professor of Internal Medicine, Co-Director of the Hanna and Mark Gleiberman Head and Neck Cancer Center, and Disease Team Leader–Head and Neck at UC San Diego Moores Cancer Center, answers questions asked by the audience during her CME/NCPD–approved activity with i3 Health, Recurrent/Metastatic Head…
…
continue reading
1
Additional Advances in Soft Tissue Sarcoma With Brian Rubin, MD, PhD
10:39
10:39
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
10:39
Last year, Brian Rubin, MD, PhD, Chair of Pathology and Laboratory Medicine and the Chief of Diagnostics at the Cleveland Clinic, served as co-chair for i3 Health's continuing medical education CME NCPD #virtualtumorboard: Multidisciplinary Management of Advanced Soft Tissue Sarcoma. In this interview, Dr. Rubin sat down with Oncology Data Advisor …
…
continue reading
1
Additional Advances in HER2-Positive Metastatic Colorectal Cancer Research: Christopher Lieu, MD
8:11
8:11
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
8:11
Dr. Christopher Lieu, Associate Director of Clinical Research at the University of Colorado Cancer Center and Vice Chair of the National Comprehensive Cancer Network (NCCN), is currently serving as chair of i3 Health's online activity, live webinar, and meeting series, Hitting the Target in HER2-Positive Metastatic Colorectal Cancer. With numerous …
…
continue reading
1
Additional Advances in aTTP Research and Clinical Trials With Spero Cataland, MD
8:47
8:47
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
8:47
Dr. Spero Cataland, Professor of Internal Medicine and the Benign Hematology Section Head at The Ohio State University, Wexner Medical Center, is currently serving as chair of i3 Health's free CME/NCPD activity and Hematology Fellows Lecture Series, Current Standards and New Directions in Treatment of Acquired Thrombotic Thrombocytopenic Purpura (a…
…
continue reading
1
Additional Advances in Esophagogastric Cancer Research and Clinical Trials With Jaffer Ajani, MD
7:18
7:18
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
7:18
Last year, Jaffer Ajani, MD, Professor in the Department of Gastrointestinal (GI) Medical Oncology at MD Anderson Cancer Center, served as co-chair of i3 Health's Virtual Tumor Board, Building Comprehensive Care Plans in Esophagogastric Cancers, along with Lei Zhao, MD, PhD, Assistant Professor of Pathology at Brigham and Women's Hospital, and Kell…
…
continue reading
1
Highlights of Multiple Myeloma Research Presented at ASH With Urvi Shah, MD
16:13
16:13
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
16:13
At the recent American Society of Hematology (ASH) Annual Meeting, numerous updates were presented with the potential to impact practice in relapsed/refractory multiple myeloma. While at the meeting, Urvi Shah, MD, Assistant Attending in the Myeloma Service at Memorial Sloan Kettering Cancer Center, shares some of most significant highlights of the…
…
continue reading
1
Additional Advances in Advanced Prostate Cancer With Tanya Dorff, MD
8:45
8:45
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
8:45
Recently, Tanya Dorff, MD, Division Chief of the Genitourinary Disease Program at City of Hope, served as faculty for i3 Health's CME/NCPD-approved activity, Evolving Treatment Concepts and New Data in Advanced Prostate Cancer. Since recording, a plethora of new data and treatment options have been made available for prostate cancer, as well as add…
…
continue reading
1
Additional Advances in SCLC Radiotherapy With Henry Park, MD, MPH + Free CME/NCPD/CPE Podcast
52:30
52:30
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
52:30
Recently, Dr. Henry Park, Chief of Thoracic Radiotherapy at Smilow Cancer Network of Yale School of Medicine, served as faculty for i3 Health’s CME/NCPD/CPE–approved activity, Optimizing Treatment Selection, Sequencing, and Tolerability in Small Cell Lung Cancer (SCLC). This month, numerous updates in the use of radiotherapy for SCLC were presented…
…
continue reading
1
Additional Advances in CRPC Research and Clinical Trials With Kathleen Burns, MSN, NP
5:17
5:17
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
5:17
In recent years, numerous developments have occurred in metastatic castration-resistant prostate cancer (CRPC) treatment and management. Last year, Kathleen Burns, MSN, NP, Nurse Practitioner in the Division of Genitourinary Medical Oncology at City of Hope Comprehensive Cancer Center, recorded an activity with i3 Health titled Overcoming Nursing M…
…
continue reading
1
Additional Advances in PI3K Inhibitor Research & Clinical Trials With Janie Metsker, RN, BSN, CN-BN
5:26
5:26
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
5:26
Click here to view and claim credit for Managing Toxicities of Novel Breast Cancer Therapies: PI3K Inhibitors, an accredited CME/NCPD/CPE activity by i3 Health: https://i3health.com/odabc-pi3k.Phosphatidylinositol-3-kinase (PI3K) inhibitors are effective treatment for patients with breast cancer but can be associated with significant hyperglycemia …
…
continue reading
1
Faculty Interview & Free CME/NCPD Activity: Graft-Versus-Host Disease
1:11:21
1:11:21
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
1:11:21
Click here to claim CME/NCPD credit for this activity: i3health.com/oda-gvhdThis audio includes both the additional updates interview and complete podcast from i3 Health’s CME/NCPD activity New Opportunities for Improved Patient Outcomes in Graft-Versus-Host Disease.First, listen along as Dr. Shernan Holtan shares the latest data from the BTM CTN 1…
…
continue reading
1
Faculty Interview & Free CME/NCPD Activity: Chemotherapy-Induced Neutropenia
1:06:07
1:06:07
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
1:06:07
In 2022, Dr. Maura Abbott, Associate Professor of Nursing at the Columbia University School of Nursing, served as faculty for i3 Health’s CME/NCPD approved activity, New Insights Into Preventing and Managing Chemotherapy-Induced Neutropenia. Now, in this follow-up interview with Oncology Data Advisor, Dr. Abbott reinforces the importance of educati…
…
continue reading
1
Additional Advances in Non–Small Cell Lung Cancer Research and Clinical Trials with Ticiana Leal, MD
1:18:26
1:18:26
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
1:18:26
Last year, Dr. Ticiana Leal, Director of the Thoracic Medical Oncology Program at Winship Cancer Institute of Emory University, recorded a continuing medical education (CME)/nursing continuing professional development (NCPD)–accredited activity titled Harnessing Immunotherapy-Based Strategies for Advanced Non–Small Cell Lung Cancer (NSCLC). With nu…
…
continue reading
1
Additional Advances in Graft-Versus-Host Disease Research and Clinical Trials: Shernan Holtan, MD
4:36
4:36
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
4:36
In 2022, Dr. Shernan Holtan, Associate Professor at the University of Minnesota Medical School, recorded a CME/NCPD activity centered on new therapeutic avenues for improved patient outcomes in graft-versus-host-disease (GVHD). Recently, at the American Society of Hematology (ASH) Annual Meeting, she presented results of the BMT CTN 1703 trial, whi…
…
continue reading
1
Additional Advances in NSCLC Research and Clinical Trials With Beth Sandy, MSN, CRNP
15:52
15:52
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
15:52
Click here to view and claim credit for Harnessing Immunotherapy-Based Strategies for Advanced Non–Small Cell Lung Cancer, an accredited CME/NCPD activity provided by i3 Health: i3health.com/nsclc-immunotherapyJust under a year ago, Beth Sandy, MSN, CRNP, a Thoracic Oncology Nurse Practitioner at the University of Pennsylvania Abramson Cancer Cente…
…
continue reading
1
Additional Advances in Immune Thrombocytopenia Research and Clinical Trials
9:52
9:52
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
9:52
In 2022, Allison Imahiyerobo, an Advanced Practice Nurse at the Englewood Health Physician Network in New Jersey, led a continuing medical education (CME)/nursing continuing professional development (NCPD)–approved activity with i3 Health, New Insights and Avenues for Improved Patient Outcomes in Immune Thrombocytopenia. A year later, Ms. Imahiyero…
…
continue reading
1
Additional Advances in Chemotherapy-Induced Neutropenia Research and Clinical Trials
10:14
10:14
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
10:14
In 2022, Dr. Maura Abbott, Associate Professor of Nursing at the Columbia University School of Nursing, served as faculty for i3 Health’s CME/NCPD approved activity, New Insights Into Preventing and Managing Chemotherapy-Induced Neutropenia. Now, in this follow-up interview with Oncology Data Advisor, Dr. Abbott reinforces the importance of educati…
…
continue reading
1
Additional Advances in Myelofibrosis Research and Clinical Trials With John Mascarenhas, MD
12:45
12:45
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
12:45
Myelofibrosis is a rare myeloproliferative neoplasm characterized by the buildup of scar tissue in the bone marrow, leading to decreased erythropoiesis, progressive bone marrow failure, and anemia. Currently, the discovery of the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway's role in the pathogenesis of myelofibr…
…
continue reading
1
Additional Advances in Acute Leukemia Research and Clinical Trials: Amir Fathi, MD
7:27
7:27
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
7:27
In January 2022, Dr. Amir Fathi, Associate Professor of Medicine at Harvard Medical School, served as faculty for Therapy of B-Cell Acute Lymphoblastic Leukemia (ALL): an Evolving Landscape, presented during the ODACon Rare Hematologic Malignancies Symposium. Recently, numerous significant updates in both ALL and acute myeloid leukemia (AML) were p…
…
continue reading
1
Additional Advances in Multiple Myeloma Research and Clinical Trials With Shaji Kumar, MD
8:48
8:48
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
8:48
Visit i3health.com/relapsed-refractory-multiple-myeloma to book a live or virtual meeting at your own institution and hear more expert perspectives from Dr. Kumar or other esteemed multiple myeloma faculty!Currently, Dr. Shaji Kumar, Professor of Hematological Malignancies at the Mayo Clinic Cancer Center, is the chair of Optimizing Treatment Seque…
…
continue reading
1
Additional Advances in Squamous NSCLC Research and Clinical Trials with Mark Kris, MD
11:10
11:10
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
11:10
In 2022, Dr. Mark Kris, the William and Joy Ruane Chair in Thoracic Oncology at Memorial Sloan Kettering Cancer Center, served as chair of Optimizing Management of Metastatic Squamous Non–Small Cell Lung Cancer (NSCLC), a continuing medical education (CME)/nursing continuing professional development (NCPD) activity. A year later, Dr. Kris sat down …
…
continue reading
1
Additional Advances in Waldenstrom Macroglobulinemia Research and Clinical Trials: Morie Gertz, MD
5:05
5:05
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
5:05
Since the original activity, Treatment Advances in Waldenstrom Macroglobulinemia, was originally presented and recorded, there have been several significant updates in the treatment and management of WM.Dr. Gertz recently sat down with Oncology Data Advisor again to discuss these updates and share all that has occurred in this evolving field. Don't…
…
continue reading